Cadrenal Therapeutics (CVKD) PT Lowered to $13 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts CVKD Hot Sheet
Price: $1.08 -0.92%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 35
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 35
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Cadrenal Therapeutics (NASDAQ: CVKD) to $13.00 (from $32.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Google: Introducing Gemini 4 Argon
- Goldman Sachs Upgrades TC Energy (TRP) to Buy
- Lockheed Martin wins over $250M in U.S. Navy and Air Force deals
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
